Pharmaceutical sales for age-related macular degeneration (AMD) marketplaces were projected to be $4.9 billion in 2016, and it’s expected to reach a price of $11.5 billion in 2026, with a Compound Annual Growth Rate (CAGR) rise of 8.9%, stated by →
........................................................................ You can create a free account with us to gain access to just released news and press releases about leading companies from across the world. Your free account can provide you with the latest industry and corporate information to help you take quick business decisions. With your free account, you can be amongst the first ones to know of the latest happenings. So Signup now !!.